The National AIDS Control Programme Phase IV (NACP-IV) target was to achieve 'Zero new infections, zero discrimination, zero AIDS deaths'. The key intervention promoted under NACP for 'zero new infections' among people who inject drugs (PWID) is:

• A Antiretroviral therapy for all PWID regardless of CD4 count
• B Opioid substitution therapy (buprenorphine/methadone) as part of Targeted Interventions (TI) ✓
• C Mandatory HIV testing before dispensing needles
• D Restriction of needle and syringe exchange programmes in non-endemic states

Explanation

Under NACP, Targeted Interventions (TI) for PWID include Needle Syringe Exchange Programmes (NSEP) and Opioid Substitution Therapy (OST) with buprenorphine or methadone. OST reduces injecting frequency and HIV transmission. TIs are run through NGO networks and are evidence-based harm reduction strategies. Mandatory testing before needle exchange is not part of the programme — that would deter uptake.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.